The role of pulmonary metastasectomy in the treatment of disseminated clear renal cell carcinoma
Authors:
Josef Vodička 1; Vladimír Špidlen 1; Jakub Fichtl 1; Petr Mukenšnabl 2; Lucie Šefrhansová 3; Milena Roušarová 4; Milan Hora 5
Authors place of work:
Chirurgická klinika LF UK, Plzeň
1; Šiklův patologicko-anatomický ústav LF UK, Plzeň
2; Onkologická a radioterapeutická klinika LF UK, Plzeň
3; Národní onkologický registr FN, Plzeň
4; Urologická klinika LF UK, Plzeň
5
Published in the journal:
Ces Urol 2014; 18(2): 112-118
Category:
Original article
Summary
Introduction:
At the time of diagnosis, up to one third of patients with clear renal cell carcinoma have a disseminated disease, and half of patients with the localized disease will progress in the future. Dissemination into the lungs develops most frequently.
Purpose:
Retrospective analysis of a group of patients undergoing surgery due to pulmonary metastases of clear renal cell carcinoma over a period of twelve years.
Material and methods:
Between 2001 and 2012, 21 patients, including 14 males, with a mean age of 65.7 years, underwent surgery at the authors’ department. Those patients who had undergone a radical resection for renal cell carcinoma, who had no extra-pulmonary metastases, and whose pulmonary metastases appeared to be radically removable according to pre-operative assessments, were indicated for the pulmonary metastatectomy. Solitary metastases were found in 11 patients, multiple metastases in the remaining patients. Four patients had bilateral metastases. The medial of the symptom-free period since nephrectomy was 24 months.
Results:
A total of 17 unilateral and 4 bilateral surgeries were performed. The most common type of surgery included wedge pulmonary resections (12 procedures). A total of 43 metastases were radically resected. Perioperative morbidity was 9.5% with zero mortality. At the time of publication, 57.1% of those that underwent a metastasectomy were alive, with a with median survival time of 44.3 months. Three-year and five-year survival rates in the group were 57% and 49%, respectively. Nine patients (42.9%) are alive after the metastasectomy without disease progression; the median was 24 months.
Conclusion:
The presented results confirm the positive role of metastasectomy in the treatment of pulmonary metastases of clear renal cell carcinoma. Long-term survival following pulmonary metastasectomy can be expected in solitary, metachronic metastases of a small size with a disease free interval > 1 year following nephrectomy, with the absence of metastases in the regional lymphatic nodes and R0 resection.
Key words:
metastasectomy, pulmonary metastases, clear renal cell carcinoma.
Zdroje
1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61(2): 69–90.
2. http://www.svod.cz/analyse.php?modul=incmor
3. Lipworth L, Tarone RE, McLaughlin JK. The epidemiology of renal cell carcinoma. J Urol 2006; 176(6 Pt 1): 2353–2358.
4. http://www.uroweb.cz/index.php?pg=dg-nadory-ledvin-epidemiologie-ceska-republika-stadia-onemocneni
5. Beneš P. Metastazující karcinom ledviny – současné možnosti léčby. Urol Praxi 2010; 11(4): 180–188.
6. Yano T, Shoji F, Maehara Y. Current status of pulmonary metastasectomy from primary epithelial tumors. Surg Today 2009; 39(2): 91–97.
7. Davidson RS, Nwogu CE, Brentjens MJ, Anderson TM. The surgical management of pulmonary metastasis: current concepts. Surg Oncol 2001; 10(1–2): 35–42.
8. Kanzaki R, Higashiyama M, Fujiwara A, et al. Long-term results of surgical resection for pulmonary metastasis from renal cell carcinoma: a 25-year single-institution experience. Eur J Cardiothorac Surg 2011; 39(2): 167–172.
9. Chen F, Fujinaga T, Shoji T, et al. Pulmonary resection for metastasis from renal cell carcinoma. Interact Cardiovasc Thorac Surg 2008; 7(5): 825–828.
10. Hofmann HS, Neef H, Krohe K, Andreev P, Silber RE. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur Urol 2005; 48(1): 77–81.
11. Kondo H, Okumura T, Ohde Y, Nakagawa K. Surgical treatment for metastatic malignancies. Pulmonary metastasis: indications and outcomes. Int J Clin Oncol 2005; 10(2): 81–85.
12. Swanson DA. Surgery for metastases of renal cell carcinoma. Scand J Surg 2004; 93(2): 150–155.
13. Renaud S, Falcoz PE, Olland A, Massard G. Should mediastinal lymphadenectomy be performed during lung metastasectomy of renal cell carcinoma? Interact Cardiovasc Thorac Surg. 2013; 16(4): 525–528.
14. Hora M, Stránský P, Eret V, et al. Integrace chirurgické a biologické léčby u pokročilého renálního karcinomu. Ces Urol 2011; 15(3): 149–157.
15. Dindo D, Demartines N, Clavien PA. Classification of surgical complications. A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240(2): 205–213.
16. Dominguez-Ventura A, Nichols FC 3rd. Lymphadenectomy in metastasectomy. Thorac Surg Clin 2006; 16(2): 139–143.
17. Internullo E, Cassivi SD, Van Raemdonck D, Friedel G, Treasure T; ESTS Pulmonary Metastasectomy Working Group. Pulmonary metastasectomy: a survey of current practice amongst members of the European Society of Thoracic Surgeons. J Thorac Oncol 2008; 3(11): 1257–1266.
18. García-Yuste M, Cassivi S, Paleru C. Thoracic lymphatic involvement in patients having pulmonary metastasectomy: incidence and the effect on prognosis. J Thorac Oncol 2010; 5(6 Suppl 2): S166–169.
19. Kudelin N, Bölükbas S, Eberlein M, Schirren J. Metastasectomy with standardized lymph node dissection for metastatic renal cell carcinoma: an 11-year single-center experience. Ann Thorac Surg 2013; 96(1): 265–270.
20. Volkmer BG, Gschwend JE. Value of metastases surgery in metastatic renal cell carcinoma. Urologe A 2002; 41(3): 225–230.
21. Chao YK, Chang HC, Wu YC, et al. Management of lung metastases from colorectal cancer: video-assisted thoracoscopic surgery versus thoracotomy--a case-matched study. Thorac Cardiovasc Surg 2012; 60(6): 398–404.
22. Hornbech K, Ravn J, Steinbrüchel DA. Outcome after pulmonary metastasectomy: analysis of 5 years consecutive surgical resections 2002–2006. J Thorac Oncol. 2011; 6(10): 1733–1740.
23. Eckardt J, Licht PB. Thoracoscopic versus open pulmonary metastasectomy: a prospective, sequentially controlled study. Chest 2012; 142(6): 1598–1602.
24. Cerfolio RJ, Bryant AS, McCarty TP, Minnich DJ. A prospective study to determine the incidence of non-imaged malignant pulmonary nodules in patients who undergo metastasectomy by thoracotomy with lung palpation. Ann Thorac Surg 2011; 91(6): 1696–1700.
25. Pfannschmidt J, Dienemann H. Current surgical management of pulmonary metastases. Zentralbl Chir 2009; 134(5): 418–424.
26. Erhunmwunsee L, D’Amico TA. Surgical management of pulmonary metastases. Ann Thorac Surg 2009; 88(6): 2052–2060.
27. Welter S, Theegarten D, Trarbach T, et al. Safety distance in the resection of colorectal lung metastases: a prospective evaluation of satellite tumor cells with immunohistochemistry. J Thorac Cardiovasc Surg 2011; 141(5): 1218–1222.
28. Pereszlenyi A, Rolle A, Koch R, et al. Resection of multiple lung metastases – where are the limits? Bratisl Lek Listy 2005; 106(8-9): 262–265.
29. Ding JH, Chua TC, Glenn D, Morris DL. Feasibility of ablation as an alternative to surgical metastasectomy in patients with unresectable sarcoma pulmonary metastases. Interact Cardio-vasc Thorac Surg 2009; 9(6): 1051–1053.
30. Doležel J, Veverková L, Jedlička V, et al. Mediastinální lymfadenektomie v chirurgii plicních metastáz. Rozhl Chir 2009; 88(5): 259–261.
31. Loehe F, Kobinger S, Hatz RA, et al. Value of systematic mediastinal lymph node dissection during pulmonary metastasectomy. Ann Thorac Surg 2001; 72(1): 225–229.
32. Pfannschmidt J, Egerer G, Bischof M, Thomas M, Dienemann H. Surgical intervention for pulmonary metastases. Dtsch Arztebl Int 2012; 109(40): 645–651.
Štítky
Paediatric urologist Nephrology UrologyČlánok vyšiel v časopise
Czech Urology
2014 Číslo 2
Najčítanejšie v tomto čísle
- Intravesical therapy of urinary bladder tumours
- Aneurysmal cyst of the adrenal gland
- Classification of the penile intraepithelial neoplasias preceding invasive squamous cell carcinomas and their analogy with precancers of vulvar squamous cell carcinoma
- „Burned-out“ tumour of a testis with metastasis to retroperitoneal lymph node